Research summary
Probiotics: How Many CFU?
Probiotics are measured in colony-forming units (CFU), often expressed in billions, but the amount needed is not fixed. The probiotic definition asks for an 'adequate amount' without specifying a number, and human studies have examined a wide range of CFU doses. Whether a higher dose works better than a lower one depends on the specific strain and the condition studied. For one endpoint, antibiotic-associated diarrhoea, pooled analyses found a higher CFU dose of the same probiotic more protective than a lower dose, whereas for several other endpoints no clear dose-response was identified.[1], [2]
What a CFU is and what 'adequate' means
Probiotic doses are counted in colony-forming units, or CFU, which estimate the number of live microorganisms in a serving and are commonly listed in billions. The widely used probiotic definition requires that an 'adequate amount' be administered to obtain a health benefit, but it does not state what that amount should be. A review of dose-response in human studies notes that this leaves the target CFU undefined, and the doses tested across trials vary widely rather than converging on a single number.[1]
Dose-response is strain- and endpoint-specific
Across human studies, a higher CFU dose does not reliably translate into a larger effect for every use. A review summarizing meta-analyses and head-to-head dose comparisons found a dose-response relationship for some endpoints, including antibiotic-associated diarrhoea, while no dose-response could be identified for several others such as necrotising enterocolitis, atopic dermatitis, slow intestinal transit, and irritable bowel syndrome relief. The same review notes one meta-analysis in which higher doses, greater than about 10^11 CFU, were more effective than lower doses for a blood-pressure endpoint. The practical implication is that the relevant CFU amount is specific to the strain and the condition being studied.[1], [2]
A worked example: antibiotic-associated diarrhoea
Antibiotic-associated diarrhoea is the endpoint where a CFU dose effect is most consistent. A systematic review and meta-analysis of 42 randomized controlled trials in adults reported that co-administering probiotics with antibiotics lowered the risk of antibiotic-associated diarrhoea, and a subgroup analysis comparing a higher versus a lower CFU dose of the same probiotic found the higher dose more protective. Effectiveness was also limited to certain species. This illustrates that, where a dose-response exists, it has been characterized for a particular indication and strain set rather than as a general rule for all probiotics.[1], [2]
Limitations
The evidence on CFU dosing does not support a single recommended number that applies across products or conditions. Observed dose-response relationships are tied to specific strains and endpoints and cannot be extrapolated to other uses; the absence of a detected dose-response for many endpoints reflects limited data rather than a proven lack of effect. The dose-response overview is a narrative review, and one of its authors had financial ties to a nutrition company. These findings describe what has been studied and are not medical advice or a basis for selecting a dose.[1], [2]
References
- A review of dose-responses of probiotics in human studies.. Beneficial microbes. 2017. Narrative review View source →
- Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.. BMJ open. 2021. Systematic review and meta-analysis View source →